GlassScriptPhysician profile
Ryan L Zwick
NPI 1184283822
$31,833.22
in general payments reported to CMS, 2019-2025
17 companies · $697 in 2025
The $697 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29K · 2024: $2,595 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $3,797 · Travel and Lodging: $3,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $3,797.06 |
| Travel and Lodging | $3,036.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17,108.51 | 2023-2025 | Wavewriter Alpha Prime 16, Vercise, Intracept |
| Medtronic, INC. | $11,629.56 | 2023 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Nevro Corp. | $1,158.60 | 2023-2024 | Senza |
| Saluda Medical Americas, INC. | $413.06 | 2024-2025 | Evoke |
| Abbott Laboratories | $330.05 | 2024 | Eterna, Proclaim |
| Vertos Medical, INC. | $283.39 | 2023-2024 | Mild Device Kit |
| Nalu Medical, INC. | $169.23 | 2024-2025 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $168.14 | 2023 | Intracept |
| Globus Medical, INC. | $166.04 | 2025 | Senza |
| Painteq LLC | $122.11 | 2024 | Painteq |
| Mml US, INC. | $110.07 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $56.50 | 2023 | Sprint Pns System |
| Curonix LLC | $33.40 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $25.98 | 2025 | |
| Merck Sharp & Dohme LLC | $24.08 | 2025 | Bridion |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $19.22 | 2025 | Prospera |
| Averitas Pharma INC. | $15.28 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Zwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.